U-Blot® Research Grade Anti-Human CD152/CTLA4 (REGN4659)Cat. No. WA1312Request quote
Size: 50ug/100ug
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade Anti-Human CD152/CTLA4 (REGN4659)Cat. No. WA1312
U-Blot® Research Grade Anti-Human CD152/CTLA4 (ONC-392)Cat. No. WA1311
U-Blot® Research Grade Anti-Human CD152/CTLA4 (JMW-3B3)Cat. No. WA1310
U-Blot® Research Grade Anti-Human CD152/CTLA4 (HBM4003)Cat. No. WA1309
U-Blot® Research Grade Anti-Human CD152/CTLA4 (GIGA-564)Cat. No. WA1308
U-Blot® Research Grade Anti-Human CD152/CTLA4 (BMS-986288)Cat. No. WA1307
U-Blot® Research Grade Anti-Human CD152/CTLA4 (BMS-986249)Cat. No. WA1306
U-Blot® Research Grade Anti-Human CD152/CTLA4 (BMS-986218)Cat. No. WA1305
U-Blot® Research Grade Anti-Human CD152/CTLA4 (BAT 4706)Cat. No. WA1304
U-Blot® Research Grade Anti-Human CD152/CTLA4 (ADU-1604)Cat. No. WA1303
U-Blot® Research Grade Anti-Human CD152/CTLA4 (ADG 126)Cat. No. WA1302
U-Blot® Research Grade Anti-Human CD152/CTLA4 (ADG 116)Cat. No. WA1301